Malaria Diagnostics Industry Overview
The global Malaria Diagnostics Market size is projected to reach USD 1.2 billion by 2030, expanding at a CAGR of 5.4%, according to a new report by Grand View Research, Inc. Rising prevalence of the tropical disease in endemic countries, development of novel diagnostic techniques, and rising investments by regional governments and private investors are expected to propel market growth. Malaria is one of the most widespread life-threatening diseases, commonly occurring in the tropical and subtropical regions due to changing climate, low economic growth, underdeveloped healthcare infrastructure, and lack of access to advanced treatment.
Increasing number of government initiatives and investments by market participants are also anticipated to fuel market growth in the near future. Use of antimalarial treatments options that were abundantly available in the African region were used for the management and control of spread during the COVID-19 pandemic. The market noticed a significant boost during the COVID-19 outbreak owing to the ever-increasing malaria cases in addition to the COVID-19 virus.
A large number of malarial elimination programs are being undertaken by major companies to reduce the disease prevalence. For instance, Novartis’s Malaria Initiative was aimed at facilitating malaria elimination and control. Along with various organizations, the company has provided non-profit treatment to 750 million people across 60 countries. Thus, such initiatives are anticipated to facilitate the development of novel technologies and aid in market penetration.
Malaria Diagnostics Market Segmentation
Grand View Research has segmented the global malaria diagnostics market on the basis of technology and region:
Based on the Technology Insights, the market is segmented into Microscopy, Rapid Diagnostic Tests (RDTs) and Molecular Diagnostic Tests.
- The Rapid Diagnostic Tests (RDTs) segment dominated the market and accounted for a revenue share of 53.7% in 2021. Microscopy was the second-largest segment owing to intermittent usage of the technique for disease diagnosis. It is one of the traditional and most reliable methods for the diagnosis of the disease.
- Molecular diagnostic tests include conventional Polymerase Chain Reaction(PCR) and quantitative or Real Time-PCR (qPCR). The usage of qPCR using DNA extracted from blood samples has been used to detect low parasite counts or mixed infections. These tests are accurate, highly sensitive, and capable of detecting low parasite count.
Malaria Diagnostics Regional Outlook
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East Africa (MEA)
Key Companies Profile
The key players are constantly focusing on devising innovative product development strategies to expand their product portfolio and gain a competitive edge. Moreover, these key players are devising their mergers and acquisitions and partnership strategies to expand their business footprint.
Some prominent players in the global Malaria Diagnostics market include
- Access Bio., Inc.
- Abbott Laboratories
- Premier Medical Corporation Pvt. Ltd.
- Sysmex Partec GmbH
- bioMérieux
- Beckman Coulter, Inc.
- Siemens Healthineers
- Leica Microsystems GmbH
- Nikon Corporation
- Olympus Corporation
- Bio-Rad Laboratories, Inc.
Order a free sample PDF of the Malaria Diagnostics Market Intelligence Study, published by Grand View Research.
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]
